Acadia pharmaceuticals reports third quarter 2021 financial results

San diego--(business wire)--acadia pharmaceuticals inc. (nasdaq: acad), today announced its financial results for the third quarter ended september 30, 2021. “our third-quarter results reflect volume growth across all channels and our strong relative performance underscores our commercial team's ability to drive sales of nuplazid in a challenging environment,” said steve davis, chief executive officer. “as we close out the year, we will meet with the fda to discuss additional analyses supportin
ACAD Ratings Summary
ACAD Quant Ranking